Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients

Gastroenterology. 2009 Apr;136(4):1272-80. doi: 10.1053/j.gastro.2009.01.011. Epub 2009 Jan 16.

Abstract

Background & aims: No information is available about the frequency or factors that predict spontaneous increases in alanine aminotransferase (ALT) levels in asymptomatic Indian patients with chronic hepatitis B virus (HBV) infection who are HB e antigen (HBeAg) negative and have normal ALT levels.

Methods: We followed 217 asymptomatic patients with chronic HBV who were HBeAg negative, anti-HBe antigen (anti-HBe) positive, and had normal ALT levels. Spontaneous increases in ALT levels (ALT flares) were considered to be >2-fold the upper limit of normal (ULN) and were accompanied by HBV DNA levels>or=10(5) copies/mL or a 100-fold increase from the previously measured level.

Results: During a median follow-up period of 69.0 months, spontaneous ALT flares occurred in 43 patients (an annual rate of 4.3%), with cumulative probabilities of 10.8% and 47.3% after 5 and 10 years, respectively. Based on multinomial logistic regression, the probability of an ALT flare correlated with age>or=30 years at presentation (odds ratio [OR], 5.31; 95% confidence interval [CI]: 1.53-18.39; P=.008), male sex (OR, 4.54; 95% CI: 1.01-20.76; P=.05), and presence of a precore mutation (OR, 10.99; 95% CI: 3.67-32.92; P<.001). The median time to spontaneous ALT flare after enrollment was 25 months (range, 1-128 months; 10th percentile=3.4 months).

Conclusions: In asymptomatic patients with chronic HBV infection who have normal ALT levels and are HBeAg negative, the annual rate of ALT flares was 4.3%. Precore mutants, male sex, and age>or=30 years at presentation are independent predictors for an ALT flare. A follow-up every 3 months can capture up to 90% of flares and would help identify patients who require antiviral therapy.

MeSH terms

  • Adult
  • Alanine Transaminase / blood*
  • Biopsy
  • DNA, Viral / genetics
  • Female
  • Follow-Up Studies
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus*
  • Hepatitis B, Chronic / blood*
  • Hepatitis B, Chronic / ethnology
  • Hepatitis B, Chronic / genetics
  • Humans
  • India
  • Liver / enzymology
  • Liver / pathology
  • Logistic Models
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Mutation / genetics
  • Predictive Value of Tests
  • Promoter Regions, Genetic / genetics
  • Prospective Studies

Substances

  • DNA, Viral
  • Hepatitis B e Antigens
  • Alanine Transaminase